155 related articles for article (PubMed ID: 33735560)
1. Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma.
Park CK; Heo J; Ham WS; Choi YD; Shin SJ; Cho NH
Cancer Res Treat; 2021 Oct; 53(4):1174-1183. PubMed ID: 33735560
[TBL] [Abstract][Full Text] [Related]
2. Loss of F-Box and Leucine Rich Repeat Protein 5 (FBXL5) Expression Is Associated With Poor Survival in Patients With Hepatocellular Carcinoma After Curative Resection: A Two-institute Study.
Cho YA; Kim SE; Park CK; Koh HH; Park CK; Ha SY
Cancer Genomics Proteomics; 2023; 20(3):298-307. PubMed ID: 37093682
[TBL] [Abstract][Full Text] [Related]
3. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
4. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
6. Low Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Ren W; Xue B; Chen M; Liu L; Zu X
Clin Genitourin Cancer; 2019 Jun; 17(3):e433-e439. PubMed ID: 30773312
[TBL] [Abstract][Full Text] [Related]
7. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.
NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J
Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054
[TBL] [Abstract][Full Text] [Related]
8. RAB27A is an independent prognostic factor in clear cell renal cell carcinoma.
An HJ; Song DH; Koh HM; Ko GH; Lee JH; Kim DC; Yang JW; Kim MH; Seo DH; Jang SM; Lee JS
Biomark Med; 2019 Mar; 13(4):239-247. PubMed ID: 30661368
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
[TBL] [Abstract][Full Text] [Related]
10. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
12. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
[TBL] [Abstract][Full Text] [Related]
13. Leishmania donovani inhibits ferroportin translation by modulating FBXL5-IRP2 axis for its growth within host macrophages.
Das NK; Sandhya S; G VV; Kumar R; Singh AK; Bal SK; Kumari S; Mukhopadhyay CK
Cell Microbiol; 2018 Jul; 20(7):e12834. PubMed ID: 29470856
[TBL] [Abstract][Full Text] [Related]
14. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
[TBL] [Abstract][Full Text] [Related]
15. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
17. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma.
Wei C; Lai YQ; Li XX; Ye JX
Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
[TBL] [Abstract][Full Text] [Related]
19. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
20. Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbidities.
Haake SM; Brooks SA; Welsh E; Fulp WJ; Chen DT; Dhillon J; Haura E; Sexton W; Spiess PE; Pow-Sang J; Rathmell WK; Fishman M
Urol Oncol; 2016 Mar; 34(3):122.e1-7. PubMed ID: 26546482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
